Cordy Joanna M, Hussain Ishrut, Dingwall Colin, Hooper Nigel M, Turner Anthony J
Proteolysis Research Group, School of Biochemistry and Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11735-40. doi: 10.1073/pnas.1635130100. Epub 2003 Sep 22.
beta-Secretase (BACE, Asp-2) is a transmembrane aspartic proteinase responsible for cleaving the amyloid precursor protein (APP) to generate the soluble ectodomain sAPPbeta and its C-terminal fragment CTFbeta. CTFbeta is subsequently cleaved by gamma-secretase to produce the neurotoxic/synaptotoxic amyloid-beta peptide (Abeta) that accumulates in Alzheimer's disease. Indirect evidence has suggested that amyloidogenic APP processing may preferentially occur in lipid rafts. Here, we show that relatively little wild-type BACE is found in rafts prepared from a human neuroblastoma cell line (SH-SY5Y) by using Triton X-100 as detergent. To investigate further the significance of lipid rafts in APP processing, a glycosylphosphatidylinositol (GPI) anchor has been added to BACE, replacing the transmembrane and C-terminal domains. The GPI anchor targets the enzyme exclusively to lipid raft domains. Expression of GPIBACE substantially up-regulates the secretion of both sAPPbeta and amyloid-beta peptide over levels observed from cells overexpressing wild-type BACE. This effect was reversed when the lipid rafts were disrupted by depleting cellular cholesterol levels. These results suggest that processing of APP to the amyloid-beta peptide occurs predominantly in lipid rafts and that BACE is the rate-limiting enzyme in this process. The processing of the APP695 isoform by GPI-BACE was up-regulated 20-fold compared with wild-type BACE, whereas only a 2-fold increase in the processing of APP751/770 was seen, implying a differential compartmentation of the APP isoforms. Changes in the local membrane environment during aging may facilitate the cosegregation of APP and BACE leading to increased beta-amyloid production.
β-分泌酶(BACE,天冬氨酸蛋白酶-2)是一种跨膜天冬氨酸蛋白酶,负责切割淀粉样前体蛋白(APP),以生成可溶性胞外结构域sAPPβ及其C端片段CTFβ。随后,CTFβ被γ-分泌酶切割,产生在阿尔茨海默病中积累的神经毒性/突触毒性淀粉样β肽(Aβ)。间接证据表明,淀粉样生成性APP加工可能优先发生在脂筏中。在此,我们发现,使用 Triton X-100作为去污剂,从人神经母细胞瘤细胞系(SH-SY5Y)制备的脂筏中,野生型BACE相对较少。为了进一步研究脂筏在APP加工中的意义,已将糖基磷脂酰肌醇(GPI)锚添加到BACE中,取代跨膜和C端结构域。GPI锚将该酶专门靶向脂筏结构域。GPI-BACE的表达显著上调了sAPPβ和淀粉样β肽的分泌水平,高于过表达野生型BACE的细胞所观察到的水平。当通过降低细胞胆固醇水平破坏脂筏时,这种效应被逆转。这些结果表明,APP加工成淀粉样β肽主要发生在脂筏中,且BACE是该过程中的限速酶。与野生型BACE相比,GPI-BACE对APP695亚型的加工上调了20倍,而对APP751/770的加工仅增加了2倍,这意味着APP亚型存在差异分隔。衰老过程中局部膜环境的变化可能促进APP和BACE的共分离,导致β-淀粉样蛋白生成增加。